HOME >> BIOLOGY >> NEWS
UNC HIV-AIDS screening, prevention method could become national model for cutting illness

CHAPEL HILL -- Earlier and more accurate diagnosis of acute infection with HIV, the virus that causes AIDS, is not only possible but also practical -- by pooling blood samples from people being screened for HIV and conducting nucleic acid tests on those grouped specimens.

That's the promise of a new first-of-its-kind, statewide N.C. Department of Health and Human Services effort that may become a model for cutting HIV transmission and saving lives across the nation. A news report on the program appears in this week's (May 28) issue of the Journal of the American Medical Association.

Designed and tested by University of North Carolina at Chapel Hill medical scientists together with state public health officials at HHS, the Screening and Tracing Active Transmission (STAT) program began quietly in November, its developers say, and is only now being publicly announced.

"Testing strategies employed in the program are already used by the nation's blood banks for screening donated blood," said Dr. Christopher Pilcher, chief program developer. "When used to enhance testing, the procedures are proving to be a distinct improvement over standard antibody tests. This is because antibody assays cannot detect the virus for up to two months post-infection and therefore miss the earliest, most infectious period when carriers can spread the virus before they even know they have it.

"The acute stage of the infection is almost never diagnosed in clinical practice and is always missed by routine antibody tests," said Pilcher, assistant professor of medicine at the UNC School of Medicine. "So we have always missed the diagnosis at the time when we know that people have by far the most virus in their blood and are at their most infectious. In fact, when these patients got tested in the past, they would receive a falsely reassuring negative test result. If we can catch infected people during the first weeks when routine antibody tests are still negative, t
'"/>

Contact: David Williamson
919-962-8596
University of North Carolina at Chapel Hill
29-May-2003


Page: 1 2 3

Related biology news :

1. Researchers report definitive evidence that HIV-AIDS is not from oral polio vaccine
2. DNA biochip may lead to fast genetic screening, more effective drugs
3. Leader in cancer treatment and prevention research honored
4. OHSU researchers discover possible method for early detection, prevention of premature birth
5. Colleagues to recognize research leadership in cancer detection, prevention and treatment
6. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
7. Indoor mold, building dampness linked to respiratory problems and require better prevention
8. Insight into transplant rejection might lead to novel prevention therapies
9. Scientists making advances in cancer prevention, detection and treatment to receive awards
10. Oral drug showing promise for breast cancer prevention in a mouse model
11. Novel approaches to current cellular therapies continue progress toward disease prevention

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced ... will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional ... Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted ... will cover the history of eSource, the reasons it did not take off as ... to site source, the industry is moving towards capturing data electronically for clinical trials ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this ... the only technology of its kind on the market and we were pleased that ... protective capacity of traditional cultured ingredients, creating a natural way to extend the shelf ...
(Date:7/10/2020)... KONG (PRWEB) , ... July 09, 2020 , ... ... compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish ... the PolyU research team led by Dr MA has been using the zebrafish ...
Breaking Biology Technology:
Cached News: